BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28736978)

  • 41. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.
    Li X; Yang Z; Han W; Lu X; Jin S; Yang W; Li J; He W; Qian Y
    Int J Mol Med; 2017 Aug; 40(2):311-318. PubMed ID: 28586029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K/AKT pathway.
    Wu H; Ma T; He M; Xie W; Wang X; Lu L; Wang H; Cui Y
    Phytother Res; 2024 May; 38(5):2215-2233. PubMed ID: 38411031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.
    Wang L; Yang L; Lu Y; Chen Y; Liu T; Peng Y; Zhou Y; Cao Y; Bi Z; Liu T; Liu Z; Shan H
    Cell Physiol Biochem; 2016; 38(6):2173-82. PubMed ID: 27185245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.
    Wang K; Zhuang Y; Liu C; Li Y
    Arch Biochem Biophys; 2012 Oct; 526(1):38-43. PubMed ID: 22820099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
    Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
    J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
    Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
    Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner.
    Liu T; Zhou W; Cai B; Chu J; Shi G; Teng H; Xu J; Xiao J; Wang Y
    Mol Med Rep; 2015 Sep; 12(3):4346-4351. PubMed ID: 26062523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.
    Chen Q; Sun W; Liao Y; Zeng H; Shan L; Yin F; Wang Z; Zhou Z; Hua Y; Cai Z
    Mol Med Rep; 2015 Jul; 12(1):219-25. PubMed ID: 25695619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
    Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
    Li T; Xiao Y; Huang T
    Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
    Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.
    Zhu Q; Liang X; Dai J; Guan X
    Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma.
    Shao XJ; Miao MH; Xue J; Xue J; Ji XQ; Zhu H
    Cell Physiol Biochem; 2015; 36(5):2051-62. PubMed ID: 26202364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
    Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
    Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways.
    Wang Y; Wan D; Zhou R; Zhong W; Lu S; Chai Y
    Anticancer Drugs; 2017 Oct; 28(9):959-966. PubMed ID: 28704237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.